GSK3B and urothelial carcinoma: The nuclear localization of GSK3β has been related to a mesenchymal phenotype in triple negative breast cancer and pancreatic cancer, and the increase in its expression with poor prognosis in urothelial carcinoma renal, pancreatic, leukemia and triple negative breast cancer38.